Global Dry Eye Syndrome (DES) Therapeutics Market Outlook: Allergan Plc, AFT pharmaceuticals, Johnson and Johnson Vision care, Inc. (Johnson & Johnson), Bausch Health Companies Inc.

Dry eye disease is characterized by insufficiency of tears in eye, insufficient lubrication in eye lead to sensing, redness, burning and pain in eye. The disease can be treated by various types of medication, devices which are available in the market. Growing incidence of dry eye disease is seen to give a strong momentum to the global market. There are other factors that could further push growth of the market in the near future. For instance, introduction of advanced drugs in near future, patient awareness and healthcare expenditure are expected to emerge as promising growth factor

Dry Eye Syndrome (DES) Therapeutics Market Key Players:

• Allergan Plc
• AFT pharmaceuticals
• Akorn, Inc.
• Bausch Health Companies Inc.
• Rohto Pharmaceutical Co. Ltd.
• Similasan Corporation
• I-Med Pharma Inc
• Johnson and Johnson Vision care, Inc. (Johnson & Johnson)
• Medicom Healthcare
• Alcon Laboratories, Inc.
• OASIS Medical
• Otsuka Pharmaceutical Co., Ltd.
• Reckitt Benckiser Group PLC
• Santen Pharmaceutical Co Ltd
• Scope Ophthalmics Ltd.
• Sentiss Pharma Private limited
• Shire Plc
• Thea Pharmaceuticals Limited
• Bayer AG
• Sun Pharmaceutical Industries Limited

Request for Sample @ https://bit.ly/2DBGrIZ

Dry Eye Syndrome (DES) Therapeutics Market Outlook:

The increase in the overall prevalence of dry eye syndrome is a key factor attributed to the growth of the dry eye syndrome market. The rising geriatric population across the world has led to a rise in the overall prevalence of dry eye syndrome, as tear glands weaken due to aging and can’t produce sufficient tear fluid to maintain a lubricating film over the eyes. In addition, growth in awareness about the diagnosis and treatment of the disease is also likely to propel the growth of the market.

Dry Eye Syndrome (DES) Therapeutics Market Segmental Overview:

The global dry eye syndrome (des) therapeutics market is segmented based on product type, disease type and geography.

Dry Eye Syndrome (DES) Therapeutics Market by Product Type:

• Cyclosporine
• Oral Corticosteroid
• Artificial Tears
• Omega Supplements
• Punctal Plugs
• Others

Speak to Analyst @ https://axiommrc.com/speak-to-analyst/?report=hc1880

Dry Eye Syndrome (DES) Therapeutics Market by Disease Type:

By disease types, the DES therapeutics market is segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.

Dry Eye Syndrome (DES) Therapeutics Market Report Buy Now @ https://bit.ly/2vrcBSR

Dry Eye Syndrome (DES) Therapeutics Market by Geography:

Geographically, the DES therapeutics market is studied across the key countries of North America, Europe, Asia Pacific and Rest of the World. The market for DES therapeutics is dominated by North America in 2018.

Axiom Market Research & Consulting™ offers market research and data analytics services such as syndicated market research reports, custom market research reports, business consulting, consumer/end user survey, data processing & analytical services, social media analytics across various industry verticals such as, Life Science, Chemicals &Materials, Food & Beverages, Packaging Agriculture, Power & Energy.

Market research reports are based on scientifically developed statistics and content analytics tool ‘Qual-Quant Data Model’, in which various industry vertical’s qualitative information such as market drivers, restraints, opportunities, market trends, competitive landscapes etc. are tracked and compared. The tool also helps in the extraction of market size and growth rates and compares the value chain of the industry vertical.

Ganesh Sai,
Sales & Marketing Manager,
616 Corporate Way, Suite 2-4268
Valley Cottage, NY 10989
Telephone: +1 (845) 875-9786
Email: sales@axiommrc.com

This release was published on openPR.